SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001640334-20-000232
Filing Date
2020-02-11
Accepted
2020-02-10 18:44:25
Documents
82
Reference 429
333-234673

Document Format Files

Seq Description Document Type Size
1 POS AM embi_posam.htm POS AM 1898446
2 EX-1.1 embi_ex11.htm EX-1.1 44131
3 EX-5.1 docklu51.htm EX-5.1 9610
4 EX-23.1 embi_ex231.htm EX-23.1 1602
11 docklu51img1.jpg GRAPHIC 12699
12 embi_posamimg1.jpg GRAPHIC 9493
  Complete submission text file 0001640334-20-000232.txt   9815664

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT embi-20190930.xml EX-101.INS 2175319
6 XBRL TAXONOMY EXTENSION SCHEMA embi-20190930.xsd EX-101.SCH 81788
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE embi-20190930_cal.xml EX-101.CAL 38992
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE embi-20190930_def.xml EX-101.DEF 462776
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE embi-20190930_lab.xml EX-101.LAB 642908
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE embi-20190930_pre.xml EX-101.PRE 563495
Mailing Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803
Business Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803 (949) 336-3443
Emerald Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-231951 | Film No.: 20593322
SIC: 2834 Pharmaceutical Preparations